Dasatinib (Dasatinib) — Patient-Friendly Guide (UK)
Dasatinib is a targeted cancer medicine used to treat certain types of blood cancers. It works by blocking specific cell-signalling pathways that help cancer cells grow and survive. This guide explains what dasatinib is, how it works, how it behaves in the body, how it’s typically taken, and important safety and lifestyle considerations for people in the United Kingdom.
Note: Medicines can affect people differently. Always follow the advice given by your oncology team or specialist prescriber and read the patient information leaflet supplied with your medicine.
Basic product information
| Item | Information |
|---|---|
| Generic name | Dasatinib |
| Common brand names (UK) | Sprycel® (may vary by supplier) |
| Medicine type | Tyrosine kinase inhibitor (TKI) |
| How it is taken | Oral tablets (strengths vary) |
| Typical setting | Haematology/oncology clinics |
| Where it’s used | Selected chronic and acute leukaemias, including Philadelphia chromosome–positive disease |
How dasatinib works (mechanism of action)
Dasatinib is a tyrosine kinase inhibitor. Many cancer cells use enzymes called tyrosine kinases to send signals that promote uncontrolled growth. In some cancers—particularly those involving the Philadelphia (Ph) chromosome—a “fusion” gene creates an abnormal tyrosine kinase called BCR-ABL.
Dasatinib helps by:
- Blocking BCR-ABL signalling, which can slow or stop the growth of leukaemia cells.
- In some settings, also affecting other kinases involved in cancer cell survival.
Because it targets specific signalling pathways, dasatinib is considered a targeted therapy rather than classic chemotherapy.
Pharmacokinetics: how the body handles dasatinib
Pharmacokinetics describes how a medicine is absorbed, distributed, metabolised, and eliminated. Understanding these can help with practical timing and interactions.
- Absorption: After oral dosing, dasatinib is absorbed into the bloodstream. Taking it consistently as directed is important.
- Distribution: The medicine distributes into body tissues. Protein binding is expected, meaning it largely travels in the bloodstream attached to proteins.
- Metabolism: Dasatinib is primarily metabolised in the liver by enzymes including CYP3A4 (important for drug interactions).
- Elimination: It is cleared from the body mainly via metabolism and elimination routes (largely through bile/faecal pathways).
- Half-life (time in the body): Dasatinib has a dosing interval based on its pharmacology; clinicians select the dose schedule to maintain the needed effect.
Practical takeaway: Because dasatinib depends on liver enzymes (especially CYP3A4), medicines that raise or lower CYP3A4 activity can change dasatinib exposure and increase side effects or reduce effectiveness.
What dasatinib is used for (indications in the UK)
Use of dasatinib depends on your diagnosis, previous treatment history, and specific genetic features. In the UK, dasatinib is used in adults for certain Ph chromosome–positive conditions, including:
- Chronic myeloid leukaemia (CML):
- For chronic phase CML in specific situations (for example, when appropriate for your treatment history).
- For accelerated phase and blast phase disease in specific settings.
- Philadelphia chromosome–positive acute lymphoblastic leukaemia (Ph+ ALL):
- Often in people where treatment plans align with current specialist guidance.
Important: Exact eligibility and treatment sequences can vary. Your haematology team will confirm whether dasatinib is appropriate for your condition.
Typical dosing and timing
Dasatinib tablets come in different strengths, and the dose can differ based on your diagnosis, disease phase, and other factors (including how you respond to treatment and tolerability).
Common principles (general)
- Take at the same time each day for best consistency.
- Swallow tablets whole. Do not crush or break unless your medicine guidance specifically allows it.
- Do not change your dose without specialist advice.
- Missed dose: If you miss a dose, contact your clinical team for advice rather than doubling up.
Timing with daily life
Many people take dasatinib . Your prescriber may specify morning or evening dosing depending on tolerability, blood counts, and interaction considerations.
- If dasatinib upsets your stomach, discuss timing with your team.
- If you take acid-reducing medicines, the timing (and sometimes the choice) may matter—see “Food and acid interactions” below.
Monitoring: Regular blood tests are typical. Your dose may be adjusted based on side effects or blood count changes.
Food interactions: what to know
Dasatinib can interact with food and stomach pH. Food does not necessarily “cancel” the treatment effect, but it can influence absorption. To support consistent dosing:
- Follow your exact instructions from your care team and the patient information leaflet.
- Some instructions recommend taking dasatinib . The goal is consistency day to day.
Acid-reducing medicines and stomach pH
Medicines that reduce stomach acid (for example, proton pump inhibitors and H2-blockers) can reduce dasatinib absorption. This can affect how well the medicine works.
Discuss before using:
- Proton pump inhibitors (PPIs) (e.g., omeprazole, esomeprazole)
- H2-receptor antagonists (e.g., famotidine)
Your prescriber may recommend alternatives or timing adjustments, depending on your needs.
Alcohol interactions
There is no single “universal” rule that alcohol is absolutely forbidden with dasatinib, but alcohol can still affect safety by:
- Increasing strain on the liver (important because dasatinib is metabolised in the liver).
- Worsening side effects such as fatigue, nausea, dizziness, or diarrhoea.
- Potentially increasing risk of bleeding or infections in people with low blood counts.
Practical advice:
- Ask your specialist team how much alcohol (if any) is safe for you.
- If you notice liver-related symptoms (yellowing of eyes/skin, dark urine, severe abdominal pain), seek medical advice promptly.
Medicine interactions (including key interaction types)
Dasatinib interactions are mainly driven by liver enzyme pathways (especially CYP3A4) and by changes in stomach acidity.
Avoid or use caution with CYP3A4 “inhibitors” and “inducers”
Examples of medicines that may increase dasatinib levels (risk of more side effects):
- Some antifungals (e.g., ketoconazole or similar)
- Some antibiotics (certain macrolides)
- Some antiviral medicines
- Grapefruit and Seville oranges may also affect metabolism (avoid unless your team advises otherwise)
Examples that may decrease dasatinib levels (risk of reduced effectiveness):
- Rifampicin (for tuberculosis)
- Phenytoin, carbamazepine, and some other anti-epileptics
- Some herbal products, especially St John’s wort
Blood thinning medicines (anticoagulants/antiplatelets)
In people with leukaemia, blood counts and bleeding risk can be complex. Dasatinib can also affect platelet function indirectly. If you take:
- Warfarin
- DOACs (e.g., apixaban, rivaroxaban, dabigatran)
- Aspirin or other antiplatelet medicines
you should have a personalised plan from your specialist team.
Other cancer medicines
Combining therapies can increase toxicity. Your oncology team will carefully plan combinations.
Always tell your pharmacist/doctor about:
- All medicines you take (including over-the-counter products)
- Herbal supplements
- Vitamins or “natural” remedies
Safety profile: side effects and when to get help
Like all medicines, dasatinib can cause side effects. Not everyone will experience them, and many can be managed by dose adjustments or supportive care. Because dasatinib can affect the blood and organs, monitoring is central.
Common or expected side effects
- Nausea, diarrhoea, or stomach discomfort
- Fatigue and weakness
- Headache
- Skin rash or itching
- Changes in blood counts (low white cells, red cells, or platelets)
Serious or urgent side effects (seek medical help promptly)
Contact your healthcare team urgently or seek emergency help if you develop:
- Breathing problems, new or worsening shortness of breath, chest pain, or rapid weight gain/swelling of legs/face (could indicate fluid-related effects or other complications)
- Signs of infection such as fever, chills, or persistent sore throat (especially if your blood counts are low)
- Unusual bleeding (e.g., nosebleeds that won’t stop, blood in urine/stool, severe bruising)
- Severe allergic reaction (swelling of face/lips, severe rash, difficulty breathing)
- Severe liver problems (yellowing of skin/eyes, dark urine, severe right-sided abdominal pain)
Common monitoring needs
- Full blood counts to check white cells, haemoglobin, and platelets
- Liver function tests (ALT/AST/bilirubin)
- Assessment of fluid-related symptoms and cardiovascular/pulmonary symptoms
- Response monitoring using disease markers as arranged by your specialist team
Practical tip: Keep a record of side effects (what happened, when, how severe, and any actions taken). This helps your team decide on supportive treatments or dose adjustments.
Practical use tips for daily life
- Take consistently: Try to take your dose at about the same time each day.
- Check your supply: Ensure you have enough tablets before holidays or appointments.
- Storage: Store as stated on the packaging (typically at room temperature, away from moisture and heat).
- Handling: Wash hands after handling tablets. If tablets are sensitive to handling, follow the instructions on the package.
- Missed doses: Do not “double up” unless your specialist has told you to.
- Oral care and infection prevention: Report mouth sores and fever promptly.
- Fatigue planning: Plan rest periods, pace activities, and ask about anti-nausea or symptom management if needed.
Vaccinations: If you have CML/ALL and are on active cancer treatment, vaccination choices may differ from the general population. Discuss flu/COVID vaccination timing and type with your team.
Alternative options (what your clinician may consider)
Because dasatinib is one targeted therapy option, alternatives may include other tyrosine kinase inhibitors (TKIs) depending on your diagnosis and prior response.
Other TKIs used for similar conditions
- Imatinib
- Nilotinib
- Bosutinib
- Ponatinib (selected situations)
In some cases, other strategies may be considered, such as monoclonal antibodies, combination regimens, or stem cell transplant in eligible patients—always decided by a specialist.
Why alternatives matter: Side effect profiles differ across TKIs, and individual factors (such as cardiovascular or fluid-related risks, drug interactions, and treatment history) can influence which option is best.
Market and legal context in the United Kingdom
In the UK, availability and supply of cancer medicines like dasatinib is regulated. Medicines used in oncology are typically managed through specialist pathways and medicines may be supplied via licensed pharmacies in line with national and local prescribing frameworks.
Regulatory oversight:
- Dasatinib is an authorised medicine and must be supplied according to UK legal requirements.
- For safe use, supply is linked to correct patient assessment and monitoring requirements carried out by healthcare professionals.
Pricing and access: Access may involve NHS pathways, commissioning decisions, and local formularies. For patients, eligibility for certain treatments can depend on disease phase, genetic markers, and previous response.
Where guidance comes from: Specialist societies and UK clinical bodies issue recommendations on monitoring, treatment sequencing, and safety management for CML and Ph+ ALL. Your care team will apply the most up-to-date advice relevant to your case.
Recent guidance and how it may affect use
Clinical practice for CML and Ph+ ALL evolves with evidence. Recent guidance typically focuses on:
- Optimising first-line and subsequent TKI choice based on response and tolerability.
- Using molecular monitoring (for example, transcript-level response markers) to guide ongoing therapy.
- Managing safety with structured dose modifications and supportive care.
- Minimising drug–drug interactions (especially with strong CYP3A4 modulators and acid-reducing medicines).
Because guidance can change, always rely on your specialist team for current, personalised advice.
Delivery and availability (UK)
Availability of dasatinib depends on the supply chain and the exact tablet strength. For online pharmacy services in the UK, delivery is usually arranged after verification steps and may follow standard UK courier timelines.
What you should expect when ordering:
- Order processing: Your pharmacy may confirm stock and prescription details with your healthcare team.
- Packaging: Medicines are typically delivered in secure, tamper-evident packaging.
- Cold/temperature needs: Dasatinib tablets generally do not require cold storage, but always check the label/leaflet.
- Delivery options: Delivery methods may vary by location and chosen service level.
Tip: Plan ahead to avoid running out. If you have scheduled clinic appointments or monitoring visits, coordinate your refill timing.
FAQ about dasatinib
1) Is dasatinib chemotherapy?
Dasatinib is not classic chemotherapy. It is a targeted therapy (a tyrosine kinase inhibitor) designed to block specific cancer-driving signalling pathways.
2) How soon does dasatinib start working?
Some responses can be seen relatively quickly, but the time to achieve the desired disease response varies by person and disease phase. Your team will monitor response using appropriate tests and may track molecular markers over time.
3) Can I take antacids with dasatinib?
Some stomach medicines can affect dasatinib absorption due to changes in stomach acid. This includes certain antacids, H2-blockers, and PPIs. Discuss the safest option and timing with your pharmacist or specialist team.
4) Can I drink grapefruit juice or eat grapefruit?
Grapefruit may affect drug metabolism and raise or alter levels of dasatinib. Many specialists recommend avoiding grapefruit products unless your team confirms it is safe for you.
5) What should I do if I vomit after taking a dose?
If you vomit soon after taking dasatinib, it may not be fully absorbed. Do not take an extra dose without advice. Contact your clinic or pharmacist for guidance.
6) What if I experience breathlessness or swelling?
Breathing problems, chest discomfort, rapid weight gain, or swelling should be treated seriously. Seek prompt medical advice—especially if symptoms are new or worsening.
7) Can I take painkillers or common cold medicines?
Many over-the-counter medicines may be used, but not all are suitable. Tell your pharmacist what you plan to take—particularly if you take blood thinners or if you have liver/blood count issues.
8) Are there foods I should avoid?
In addition to possible grapefruit interactions, the main practical advice is consistency with food instructions provided for your dasatinib regimen. Follow your leaflet and clinician guidance.
9) How often will I need blood tests?
Frequency varies, but blood tests are commonly required at regular intervals, particularly during the initial months, to monitor blood counts and organ function.
10) Can my dose be changed?
Yes, dose adjustments may be made based on side effects, blood counts, and response. Any change should be decided by your specialist team.
Summary
Dasatinib is an oral targeted medicine used to treat specific forms of leukaemia associated with the Philadelphia chromosome. By inhibiting disease-driving kinase activity, it can help control cancer growth. Because it is metabolised via liver pathways and can be affected by stomach acidity and other medicines, careful attention to drug interactions, consistent dosing, and regular monitoring is essential. If you experience symptoms such as fever, unusual bleeding, or breathing difficulties, seek medical help promptly.
If you have questions about your specific regimen, interactions, or side effect concerns, speak with your oncology team or pharmacist.
